Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
Select options
This product has multiple variants. The options may be chosen on the product page
Details
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
While most people chase AI stocks or compete for high‑pressure tech jobs, the real opportunity may be unfolding in AI boomtown real estate. As companies like OpenAI, Anthropic, Microsoft, and NVIDIA mint new waves of wealthy workers, demand for housing in key cities is exploding. From San Francisco to Austin, AI‑driven markets are seeing rising rents, limited inventory, and buyers preparing for massive IPO windfalls. For real estate professionals—or anyone entering the field—this surge represents one of the strongest long‑term opportunities in the industry.
Florida is ending its 1 percent emergency insurance surcharge two years ahead of schedule, saving homeowners an estimated 650 million dollars through 2028. Thanks to a calm hurricane season, fewer insurer failures, and reduced lawsuits, officials say the state’s property insurance market is now in its strongest financial position in a decade. The change offers relief for homeowners and new momentum for Florida’s real estate industry, where lower insurance costs can boost buyer confidence and support smoother transactions.
A growing political push to block institutional investors from buying single-family homes may sound like a pro-homeowner policy, but the data shows it could do the opposite. Younger and racially diverse renters rely heavily on single-family rentals as an affordable, stable alternative to buying—yet restricting investor participation would shrink this supply, pushing many families into overcrowded housing, motels, or homelessness. The real issue isn’t who buys the homes, but that America doesn’t have enough of them.
Zillow’s 2026 Agent Trends Survey reveals a major shift in what agents value most: technology that reduces mental drain. Nearly half of agents now use AI tools daily, yet most still juggle multiple platforms that sap their focus. Zillow’s upcoming unified platform, Zillow Pro, aims to streamline workflows and cut cognitive load. The survey also highlights key industry trends, including buyer financial literacy gaps, the importance of relationships for lead generation and the growing need for tech fluency among both new and seasoned real estate professionals.
Florida’s housing market is still surging, with luxury enclaves like Lake Buena Vista, Jupiter Island, and Golden Beach seeing massive six‑figure price jumps in just one year. Smaller towns such as Old Town, Cross City, and Hosford also posted steady gains, proving demand is rising statewide. For real estate professionals, these trends highlight where buyers are moving, where inventory is tight, and where future opportunities lie—making market literacy an essential advantage for anyone pursuing or expanding a career in Florida real estate.
Rhode Island is launching its sixth major housing reform package, aiming to boost affordability through zoning updates, lot splits, code changes, and the revival of single room occupancy and co‑living housing. With the state still recovering from years of underbuilding and soaring home prices, lawmakers hope these reforms will unlock new supply, ease pressure on renters and buyers, and create fresh opportunities for real estate professionals.
